Alpha-2 Adrenoceptor Agonist (Topical IOP-Lowering Agent)
Apraclonidine
Brand names: Iopidine
Adult dose
Dose: 0.5% drops: 1 drop 3 times daily (short-term, adjunctive). 1% drops: 1 drop 1 hour before and immediately after anterior segment laser procedures
Route: Topical ophthalmic
Frequency: 3 times daily (0.5%); or perioperative single doses (1%)
Clinical pearls
- Reduces intraocular pressure by decreasing aqueous humour production
- Short-term use (0.5%) to delay laser treatment or bridge therapy — high rate of tachyphylaxis and contact allergy limits chronic use
- 1% formulation used perioperatively to prevent IOP spikes after anterior segment laser (argon laser trabeculoplasty, Nd:YAG capsulotomy, iridotomy)
- NICE NG81 (Glaucoma): apraclonidine not recommended for long-term treatment; brimonidine preferred for chronic adjunctive use
- Contact dermatitis/conjunctivitis develops in ~48% over 3 months — monitor and switch if occurs
- Nasolacrimal occlusion (finger over lacrimal punctum for 60 seconds post-instillation) reduces systemic absorption
Contraindications
- Severe or unstable cardiovascular disease
- MAOIs — absolute contraindication (hypertensive crisis risk)
- Tricyclic antidepressants (caution)
- Neonates and children (systemic alpha-2 effects)
Side effects
- Ocular hyperaemia and follicular conjunctivitis (common with 0.5% chronic use)
- Contact allergy (up to 48% with prolonged use — limits long-term use)
- Upper eyelid retraction, mydriasis (sympathomimetic)
- Dry mouth and nose (systemic absorption)
- Fatigue, drowsiness
- Bradycardia and hypotension (systemic — more likely in children)
Interactions
- MAOIs — contraindicated: risk of serious hypertensive/haemodynamic crisis
- Tricyclic antidepressants — potentiation of sympathomimetic effects
- Antihypertensives — additive hypotension
Monitoring
- Intraocular pressure at each visit
- Ocular surface: follicular conjunctivitis and contact allergy signs
- Blood pressure if systemic absorption concerns
Reference: BNF; NICE NG81 (Glaucoma: diagnosis and management, 2017 updated 2022); RCOphth Guidelines on glaucoma; https://bnf.nice.org.uk/drugs/apraclonidine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme